TERMINATION AGREEMENTTermination Agreement • August 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
This TERMINATION AGREEMENT (this “Agreement”) is made and entered into as of the 4th day of June, 2011 (the “Effective Date”) by and among China Pharmaceutical Group Limited (“CPG”), having an address at 276 Zhongshan West Road Shijiazhuang, Hebei Province, People’s Republic of China; Unigene Biotechnology Co., Ltd. (“JV”), having an address at Economic and Technological Development Zone, Shijiazhuang, Hebei Province, People’s Republic of China; and Unigene Laboratories, Inc. (“Unigene”), having an address at 81 Fulton Street, Boonton, NJ 07005. CPG, JV and Unigene are each referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Technology Transfer Agreement (as defined below).
LEASE FOR REAL PROPERTYLease Agreement • August 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
THIS LEASE is made and entered into as of May 24, 2011 (the "Effective Date") by and between RCP Birch-Little Falls, LLC, a New Jersey limited liability company, whose principal business office is located at c/o Marlow Park, LLC, 80 Greenwood Avenue, Midland Park, New Jersey 07432, as 70% Tenant-in-Common, and 110 Little Falls DCLA, LLC, a New Jersey limited liability company, whose principal business office is located at c/o North Jersey Development Group, Inc., 333 Route 46, Mountain Lakes, New Jersey 07046, as 30% Tenant-in-Common (collectively, "Landlord"); and UNIGENE LABORATORIES INC., a Delaware corporation, whose principal business office is located at 81 Fulton Street, Boonton, New Jersey 07005 ("Tenant").
EQUITY SALE AND PURCHASE AGREEMENTEquity Sale and Purchase Agreement • August 9th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
THIS EQUITY SALE AND PURCHASE AGREEMENT (this "Agreement") is made the ____ day of July, 2011 (the “Effective Date”) by and between the following parties:
